Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125298192 | 12529819 | 2 | F | 20160714 | 20160706 | 20160722 | EXP | JP-ELI_LILLY_AND_COMPANY-JP201607000019 | ELI LILLY AND CO | 45.00 | YR | F | Y | 0.00000 | 20160722 | CN | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125298192 | 12529819 | 1 | PS | ZYPREXA | OLANZAPINE | 1 | Oral | UNK | U | U | 20592 | TABLET | |||||||
| 125298192 | 12529819 | 2 | C | PHENOBAL /00023201/ | PHENOBARBITAL | 1 | 0 | ||||||||||||
| 125298192 | 12529819 | 3 | C | HYDANTOL | PHENYTOIN SODIUM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125298192 | 12529819 | 1 | Hallucination, auditory |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125298192 | 12529819 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125298192 | 12529819 | Haemoglobin decreased | |
| 125298192 | 12529819 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |